logo
Select company
Select metric
$ -197KNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
46
Sector
53
Industry
50
History
50
$ 6.49Close
$ 5.06 - $ 8.78 52-Week Range
Ticker Information

Ticker

LFCR

Company Name

LIFECORE BIOMEDICAL INC

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

LIFECORE BIOMEDICAL INC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LFCR - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ -197K
3/31/2025$ 2.34M
12/31/2024$ 6.23M
9/30/2024$ -3.12M
6/30/2024$ -10.63M
3/31/2024$ 123K
6/30/2023$ 17.45M
3/31/2023$ 1.1M
12/31/2022$ 5.74M
9/30/2022$ 2.77M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LIFECORE BIOMEDICAL INC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ 512K.
  • Over the past 5 years, LIFECORE BIOMEDICAL INC's average CF - Chg. Cash has been $ 1.28M.
  • The median CF - Chg. Cash for LIFECORE BIOMEDICAL INC during this period was $ 512K
  • LIFECORE BIOMEDICAL INC reached its highest CF - Chg. Cash over the past 5 years at $ 17.45M.
  • The lowest CF - Chg. Cash recorded by LIFECORE BIOMEDICAL INC in the same timeframe $ -10.63M

LIFECORE BIOMEDICAL INC's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
OGI : ORGANIGRAM GLOBAL INC $ -14.66MCGC : CANOPY GROWTH CORP $ -48.14MARCT : ARCTURUS THERAPEUTICS HOLDINGS INC $ -63.86MQTRX : QUANTERIX CORP $ 84.85MSTIM : NEURONETICS INC $ -25.17MOM : OUTSET MEDICAL INC $ 1.7MRXST : RXSIGHT INC $ 15.95MDERM : JOURNEY MEDICAL CORP $ -3.62MASRT : ASSERTIO HOLDINGS INC $ 2.35MSMTI : SANARA MEDTECH INC $ 10.81M

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

LFCR - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -10.63M

Minimum

Jun 30, 2024

$ 17.45M

Maximum

Jun 30, 2023

$ 1.28M

Average

$ 512K

Median

CF - Chg. Cash Benchmark Analysis

The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.18M with a standard deviation of $ 44.92M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -136.09M
max$ 137.58M
average$ 1.18M
median$ 115.89K
std$ 44.92M